Is Heart Rate a Treatment Target in Heart Failure?
- First Online:
- Cite this article as:
- Reil, JC. & Böhm, M. Curr Cardiol Rep (2012) 14: 308. doi:10.1007/s11886-012-0260-3
- 168 Downloads
Clinical and experimental studies confirmed an association between elevated resting heart rate and the risk of mortality in heart failure patients. Importantly, elevated heart rate at rest has been identified as a key finding in heart failure addressing a major treatment target. This review shows that heart rate level at rest and its extent of reduction is a sensitive indicator for successful therapy in heart failure patients demonstrating the specific influence of heart rate reduction on clinical outcome in the analyzed patients. Currently, experimental data provide convincing evidence of a pathophysiological concept of heart rate reduction; nevertheless, transition from experimental results to clinical evidence needs further clarification, especially in patients with diastolic heart failure. Since heart rate can be easily determined during physical examination, decrease in heart rate of patients allows a simple hint on prognosis and efficiency of heart failure therapy.
KeywordsHeart rate Heart failure Treatment target
Clinical Trial Acronyms
Morbidity-Mortality Evaluation of the If Inhibitor Ivabradine in Patients with Coronary Artery Disease and Left Ventricular Dysfunction
Cardiac Insufficiency Bisoprolol Study II
Carvedilol or Metoprolol European Trial
Gruppo Italiano per lo Studio della Streptochianasi nell’Infarto Miocardico
Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure
Systolic Heart Failure Treatment with the If-Inhibitor Ivabradine Trial